SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-24-029936
Filing Date
2024-06-25
Accepted
2024-06-25 17:18:41
Documents
15
Period of Report
2024-06-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cdxc-20240619.htm   iXBRL 8-K 25142
2 EX-10.1 letteragreementandconsulti.htm EX-10.1 82569
6 GRAPHIC image_0.jpg GRAPHIC 8195
  Complete submission text file 0001628280-24-029936.txt   263957

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cdxc-20240619.xsd EX-101.SCH 1895
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cdxc-20240619_lab.xml EX-101.LAB 21689
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cdxc-20240619_pre.xml EX-101.PRE 12519
18 EXTRACTED XBRL INSTANCE DOCUMENT cdxc-20240619_htm.xml XML 2733
Mailing Address 10900 WILSHIRE BLVD SUITE 600 LOS ANGELES CA 90024
Business Address 10900 WILSHIRE BLVD SUITE 600 LOS ANGELES CA 90024 310-388-6706
ChromaDex Corp. (Filer) CIK: 0001386570 (see all company filings)

IRS No.: 262940963 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37752 | Film No.: 241069942
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)